Jack Reifenberg

Also affiliated with University of Cincinnati, University of Cincinnati Medical Center

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and PharmaceuticsImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Lung function and secondhand smoke exposure among children with cystic fibrosis: A Bayesian meta-analysis”.

Lung function and secondhand smoke exposure among children with cystic fibrosis: A Bayesian meta-analysis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.04.020

N/A

0DataRank · unranked

5 citations

Emrah Gecili, Teresa Pestian, Eleni‐Rosalina Andrinopoulou, Patrick Ryan, Cole Brokamp +3 more

Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease

Clinical and Translational Science(2025)10.1111/cts.70086

N/A

0DataRank · unranked

6 citations

Kei Irie, Tomoyuki Mizuno, Jack Reifenberg, Nieko Punt, Alexander A. Vinks +2 more

Hybrid Population Pharmacokinetic–Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn’s Disease

Clinical Pharmacokinetics(2025)10.1007/s40262-025-01564-7

N/A

0DataRank · unranked

6 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Model‐Informed Deep Q‐Networks to Guide Infliximab Dosing in Pediatric Crohn’s Disease

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70118

N/A

0DataRank · unranked

2 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.01.651780

N/A

0DataRank · unranked

0 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.14.664804

N/A

0DataRank · unranked

0 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, S Jeffrey Hyams +2 more